News from HealioFollowNews from HealioStay current with all the latest and breaking news from Healio. Compare headlines and media bias behind news outlets on stories breaking today.We’ve aggregated 5 of Healio’s headlines and news stories over the past 3 months. Healio’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Healio’s factuality rating is high. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.Follow Stay current with all the latest and breaking news from Healio. Compare headlines and media bias behind news outlets on stories breaking today. We’ve aggregated 5 of Healio’s headlines and news stories over the past 3 months. Healio’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Healio’s factuality rating is high. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check. Information about HealioWhere is Healio located?Healio's WebsiteMedia Bias RatingsDo you diasgree? Edit biasLearn more about Media Bias Ratings.FactualityAverage Factuality Rating: HighHighbyMedia Bias/Fact CheckLearn more about Factuality Ratings.Top Healio NewsAbortion · United StatesStates with abortion bans saw birth control prescriptions fall post-Dobbs, study finds64% Left coverage: 14 sourcesAfter the Supreme Court's Dobbs decision, fewer prescriptions for birth control pills and Plan B were filled in states with strict abortion bans, a study found.See the StoryUnited States · United StatesFDA approves Onyda XR extended-release liquid nonstimulant ADHD drugThe FDA has approved Onyda XR extended-release oral suspension for the treatment of ADHD among children aged 6 years and older, according to a press release from Tris Pharma, Inc.Onyda XR (clonidine hydrochloride, Tris Pharma) is the first and only liquid nonstimulant ADHD medication in the United States and the only approved nonstimulant ADHD drug with nighttime dosing, according to the release.See the StoryCancer · BuffaloCDC finds rural Americans dying prematurely from preventable deaths67% Left coverage: 3 sourcesThe CDC says distance and availability of services is affecting rural Americans' ability to get screened for heart disease, cancer.See the StoryLatest News StoriesMore stories